Division of Rheumatology
Every day, you use your muscles, bones and joints. Whether you’re walking, typing, eating, stretching, or just getting out of bed in the morning, you’re getting help from your body’s connective tissues.
When your musculoskeletal system isn’t working properly, you may need to see a rheumatologist.
Rheumatologists are physicians who are dedicated to diagnosing and treating diseases and conditions of the joints, muscles and bones.
The Division of Rheumatology at Northwestern Memorial Hospital deals primarily with the diagnosis and treatment of arthritis and autoimmune diseases.
Our practice of integrating clinical care with cutting-edge research in every area of rheumatology puts us shoulder-to-shoulder with the world's most renowned hospitals.
A Treatment Team You Can Trust
Our arthritis program is one of several centers in the United States funded by a Multipurpose Arthritis and Musculoskeletal Diseases Center Grant from the National Institutes of Health. The arthritis center’s multidisciplinary team diagnoses and treats arthritic, rheumatic and autoimmune disorders.
Rheumatology staff consults with colleagues in Orthopaedic Surgery and Physical Rehabilitation Medicine to provide the best possible patient care. We offer special expertise in diagnosing and treating:
Because rheumatology involves more than just one organ system, our rheumatology staff consults with pulmonary, cardiology and nephrology specialists, as well as colleagues in orthopaedic surgery and physical medicine and rehabilitation.
Our staff also works closely with dermatology specialists in areas such as psoriasis, lupus and many other diseases that have important skin manifestations.
These affiliations allow us to offer our patients:
Current initiatives include:
Our dedication to doing whatever is required to achieve the highest clinical quality and patient outcomes is why people consistently count on and recommend the Division of Rheumatology at Northwestern Memorial Hospital.
Roberta Goncalves-Marangoni, MD, PhD, and John Varga, MD, have established a novel link between intradermal adipose tissue loss and dermal fibrosis and demonstrate that adiponectin-positive intradermal progenitors give rise to dermal myofibroblasts. Adipose tissue loss and adipocyte-myofibroblast transition might be primary events in the pathogenesis of cutaneous fibrosis that represent novel potential targets for therapeutic intervention. LEARN MORE >
Thomas Schnitzer, MD, PhD, and Jeremy Marks, MD, have recently demonstrated that antibodies to NGF provide efficacy in OA and that general safety at the lower doses appears similar to placebo. Additional data on both efficacy and safety of these antibodies are needed to define the optimal dose to maximize benefit to risk. LEARN MORE >
Darcy Majka, MD, and Rowland Chang, MD, MPH, recently completed a study to determine whether autoantibodies might be risk markers for subclinical and clinical CVD development not only in patients with rheumatic diseases but in the general population as well. LEARN MORE >
Message from the Chief
Welcome to the Division of Rheumatology web page. Our mission is the prevention, cure and relief of suffering from arthritis and rheumatic diseases, providing patient-centered, integrated care guided by research-based evidence.
Our faculty include nationally and internationally recognized leaders in their fields. Further information about our research and educational programs can be found here.
Harris R. Perlman, PhD
Solovy/Arthritis Research Society Professor
Professor in Medicine - Rheumatology
Chief, Division of Rheumatology
Meet Our Team
We work in partnership with:
News and Events